Search Results
Viewing: 1051-1060 of 3170 | All
News
Despite Decreases in Recent Years, New Study Finds ATV-Related Head and Neck Injuries Among Youth Continue to Remain High
A new study conducted by researchers at the Center for Injury Research and Policy and the Department of Otolaryngology-Head and Neck Surgery at Nationwide Children’s Hospital analyzed data regarding ATV-related head and neck injuries treated in U.S. emergency departments from 1990 through 2014 involving patients younger than 18 years of age, and found an average of more than 11,000 children and teens treated for nonfatal ATV-related head and neck injuries annually – that’s approximately 31 children and teens injured each day.
Article
QREK
Considering more than 70% of healthcare information is stored in unstructured clinical notes, healthcare providers increasingly demand effective text-search systems for clinical care, QI reporting and research projects.
News
MDA Collaborates with AVI BioPharma on First Phase 2 Placebo-Controlled Clinical Trial of Exon-51 Skipping Drug as Potential Therapy for Duchenne Muscular Dystrophy
More than a decade of targeted Muscular Dystrophy Association-funded research, made possible as a result of generous public support of the MDA Labor Day Telethon and thousands of grassroots special events, has culminated in MDA providing financial assistance for the start of the first phase 2
News
Study Shows Buying Breast Milk Online is Likely to Cause Illness in Infants
Results from a study led by researchers at Nationwide Children’s Hospital found more than three-fourths of breast milk samples purchased over the Internet contained bacteria that can cause illness, and frequently exhibited signs of poor collection, storage or shipping practices.
News
FDA Grants Nationwide Children’s Hospital Researchers Safe-To-Proceed Authorization on First-In-World CAR-NK Cells Made with CRISPR/AAV
Researchers at Nationwide Children’s Hospital have received safe-to-proceed approval from the Food and Drug Administration (FDA) for Universal-Donor CD38KO CD33CAR-NK cells, to be studied in a forthcoming clinical trial. The Phase 1 trial will study the safety of the novel therapy in patients with advanced, high-risk acute myeloid leukemia (AML).
News
Depression During Pregnancy Increases Risk for Preterm Birth and Low Birth Weight
Note to Editor: Jeffrey Bridge, MD, an investigator in the Center for Innovation in Pediatric Practice in The Research Institute at Nationwide Children's Hospital, was a co-author of this study on maternal depression.
News
New National Study Highlights Dangers of Exertional Heat-Related Injuries
A new study conducted by researchers at the Center for Injury Research and Policy of The Research Institute at Nationwide Children’s Hospital examined exertional heat-related injuries that were treated in emergency departments between 1997 and 2006.
News
New Study Finds High School Lacrosse Players at Risk for Concussions, Other Injuries
Lacrosse is one of the fastest-growing high school sports in the United States, with more than 170,000 students now playing the sometimes hard-hitting game. The growing participation numbers, however, mean that more young people than ever are at risk of injury in lacrosse practice and competition.
News
New Study Finds 20 Children a Day During the Summer are Treated in U.S. Emergency Departments for Amusement Ride-Related Injuries
A new study by researchers in the Center for Injury Research and Policy of The Research Institute at Nationwide Children’s Hospital examined injuries to children related to amusement rides, which included rides at amusement parks (fixed-site rides), rides at fairs and festivals (mobile rides)
News
Phase 1 Study Shows Encouraging Data for Gene Replacement Therapy for Spinal Muscular Atrophy Type 1
A one-time intravenous infusion of the high dose of gene therapy extended the survival of patients with spinal muscular atrophy type 1 (SMA1) in a Phase 1 clinical trial, according to a study published today in the New England Journal of Medicine. The study was conducted by Researchers from Nationwide Children’s Hospital in collaboration with AveXis, Inc. and The Ohio State University College of Medicine.